Vanda Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell VNDA and other ETFs, options, and stocks.About VNDA
Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder.
CEOMihael Hristos Polymeropoulos
CEOMihael Hristos Polymeropoulos
Employees368
Employees368
HeadquartersWashington, District of Columbia
HeadquartersWashington, District of Columbia
Founded2002
Founded2002
Employees368
Employees368
VNDA Key Statistics
Market cap392.76M
Market cap392.76M
Price-Earnings ratio-4.63
Price-Earnings ratio-4.63
Dividend yield—
Dividend yield—
Average volume1.61M
Average volume1.61M
High today$6.90
High today$6.90
Low today$6.35
Low today$6.35
Open price$6.65
Open price$6.65
Volume1.92M
Volume1.92M
52 Week high$6.90
52 Week high$6.90
52 Week low$3.81
52 Week low$3.81
Stock Snapshot
Vanda Pharmaceuticals(VNDA) stock is priced at $6.70, giving the company a market capitalization of 392.76M. It carries a P/E multiple of -4.63.
On 2025-12-15, Vanda Pharmaceuticals(VNDA) stock traded between a low of $6.35 and a high of $6.90. Shares are currently priced at $6.70, which is +5.5% above the low and -2.9% below the high.
The Vanda Pharmaceuticals(VNDA)'s current trading volume is 1.92M, compared to an average daily volume of 1.61M.
During the past year, Vanda Pharmaceuticals(VNDA) stock moved between $3.81 at its lowest and $6.90 at its peak.
During the past year, Vanda Pharmaceuticals(VNDA) stock moved between $3.81 at its lowest and $6.90 at its peak.
People also own
Based on the portfolios of people who own VNDA. This list is generated using Robinhood data, and it’s not a recommendation.